Jacobs Levy Equity Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-200,808
| Closed | -$3.04M | – | 1082 |
|
|
2022
Q3 | $3.04M | Sell |
200,808
-982,868
| -83% | -$14.9M | 0.02% | 478 |
|
|
2022
Q2 | $8.88M | Buy |
1,183,676
+92,379
| +8% | +$693K | 0.07% | 301 |
|
|
2022
Q1 | $9.93M | Buy |
1,091,297
+76,741
| +8% | +$698K | 0.07% | 297 |
|
|
2021
Q4 | $7.12M | Buy |
1,014,556
+409,917
| +68% | +$2.88M | 0.05% | 362 |
|
|
2021
Q3 | $6.89M | Buy |
604,639
+26,807
| +5% | +$306K | 0.05% | 369 |
|
|
2021
Q2 | $9.25M | Buy |
577,832
+377,604
| +189% | +$6.05M | 0.06% | 313 |
|
|
2021
Q1 | $3.58M | Sell |
200,228
-341,947
| -63% | -$6.11M | 0.03% | 493 |
|
|
2020
Q4 | $7.33M | Buy |
542,175
+391,385
| +260% | +$5.29M | 0.06% | 321 |
|
|
2020
Q3 | $1.78M | Buy |
+150,790
| New | +$1.78M | 0.02% | 540 |
|